Conduit Pharmaceuticals News

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Sep 13 16:07 ET

8-K: Current report

Sep 6 17:05 ET

S-1: General form for registration of securities under the Securities Act of 1933

Sep 4 16:55 ET

8-K: Current report

Aug 16 17:03 ET

8-K: Current report

Aug 8 08:34 ET

8-K: Current report

Aug 7 17:06 ET

8-K/A: Current report (Amendment)

Jul 11 16:19 ET

8-K: Current report

Jul 1 16:35 ET

8-K: Current report

May 31 17:05 ET

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

May 2 14:16 ET

8-K: Current report

Apr 16 17:31 ET

Conduit Pharmaceuticals | NT 10-K: Others

Apr 1 16:58 ET

Conduit Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 10 00:00 ET

Conduit Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 1, 2023 16:52 ET

Conduit Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 1, 2023 16:50 ET

Conduit Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 14, 2023 16:35 ET

Conduit Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Oct 17, 2023 16:49 ET

Conduit Pharmaceuticals | 8-K/A: Current report (Amendment)

Oct 5, 2023 17:25 ET

Conduit Pharmaceuticals | 8-K: Current report

Sep 28, 2023 19:45 ET

Murphy Canyon Acquisition Corp | 8-K: Current report

Sep 20, 2023 17:40 ET